StonvexLoading…
StonvexStonvexStonvexCore line items from HYNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $5.26M | $20.37M | $14.77M | $4.68M |
Operating Income | $-174.55K | $8.92K | $43.48K | $-242.57K |
Net Income | $-118.35K | $232.69K | $31.09K | $-166.03K |
EPS (Diluted) | $-0.02 | $0.03 | Not available | Not available |
Total Assets | $477.22M | $489.38M | $454.75M | Not available |
Total Liabilities | $316.14M | $328.01M | $364.61M | Not available |
Cash & Equivalents | $13.49M | $47.60M | $26.93M | $31.20M |
Free Cash Flow OCF − CapEx | $-869.78K | $201.99K | $-463.04K | $733.28K |
Shares Outstanding | 8.10M | 8.10M | Not available | Not available |